Latest Exploration Financing News

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

Indiana Resources reports significant gold intercepts at its Minos Gold Project, extending mineralisation by 60 metres and confirming open depth potential. A new air-core drilling campaign is set to test further targets along the Lake Labyrinth Shear Zone.

Kuniko Limited has launched a partially underwritten rights issue to fund exploration at its Commonwealth Gold-Silver Project in New South Wales, aiming to capitalise on high-grade multi-metal potential in a Tier-1 jurisdiction.

Euro Manganese Inc. reported a $12.8 million loss for the nine months ended June 30, 2025, while securing $11.1 million in equity financing and amending its $20 million convertible loan facility. The company highlights ongoing funding risks as it advances its manganese projects.

Infinity Mining Limited reported a significant cash outflow in the June quarter and is pursuing divestments of its Western Australian projects to shore up finances. The company remains confident in securing additional funding to sustain operations.

Golden Horse Minerals reported a solid cash position of A$14.955 million for the June quarter, supported by a recent capital raising and plans for an additional $8.1 million raise pending shareholder approval.

Tlou Energy Limited’s latest quarterly cash flow report reveals a cautious financial position with A$2.74 million in available funding, supporting approximately 2.5 quarters of operations as exploration activities continue.

Meeka Metals reported a robust cash position of $55.6 million at the end of June 2025, supported by strong financing inflows despite significant outflows on exploration and evaluation activities.

Sky Metals Limited reported a net cash outflow in operating and investing activities for Q2 2025 but ended the quarter with A$3.43 million in cash, signaling plans for a capital raise to sustain exploration efforts.

AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.

Dreadnought Resources Limited reported a solid cash flow quarter ending June 2025, with a net cash increase of AUD 3.1 million and a funding runway extending to five quarters. The company’s financial position reflects strategic financing activity amid ongoing exploration investments.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.